Catalysts for Navinta LLC
4 tracked
Feb 17, 2026
approval
SODIUM PHENYLBUTYRATE โ FDA approval
SODIUM PHENYLBUTYRATE
โ
Feb 15, 2026
grant
WASHINGTON UNIVERSITY โ Novel Use of Fomepizole in Hepatic Ischemia Reperfusion Injury
Navinta LLC
โ
Nov 14, 2025
approval
DIAZEPAM โ FDA approval
DIAZEPAM
โ
Oct 27, 2025
approval
SEVELAMER CARBONATE โ FDA approval
Renvela
โ